EUVIMEDEUVIMED entdecken
Crossref

Adjunctive Nebulised N‐Acetylcysteine for Laryngopharyngeal Symptoms Persisting Despite Proton‐Pump‐Inhibitor Therapy: A Prospective Single‐Arm Interventional Study

Sang Heun Kim, Sumin Yi iD, Han Wool John Sung iD, Hyo One Son, Bon Seok Koo iD, Jae Won Chang iD

Clinical Otolaryngology · 13.11.2026

DOI: 10.1111/coa.70195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Otolaryngology, online erschienen am 13.11.2026. Verfasst von Sang Heun Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Chungnam National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To quantify within‐subject change in symptom, laryngoscopic and quality‐of‐life measures after 8 weeks of adjunctive nebulised N‐acetylcysteine ( NAC ) in adults with laryngopharyngeal symptoms ( LPS ) persisting despite proton‐pump‐inhibitor ( PPI ) therapy, and to explore baseline predictors of response.

Design

Prospective, single‐arm, pre–post interventional study.

Setting

Tertiary otolaryngology practice.

Participants

Seventy‐five adults with LPS persisting after ≥ 12 weeks of PPI therapy (baseline Reflux Symptom Index [ RSI ] ≥ 13 and Reflux Finding Score [ RFS ] ≥ 7); ambulatory reflux monitoring was not performed. Main Outcome Measures Change in RSI (primary). Secondary: RFS, the 12‐item Reflux Symptom Score (RSS‐12) and the laryngopharyngeal reflux health‐related quality‐of‐life instrument (LPR‐HRQoL). Treatment response (≥ 50% RSI reduction or end‐of‐treatment RSI < 13) was modelled by logistic regression.

Results

All outcomes improved at Week 8: RSI −10.2 points (95% CI −11.2 to −9.2; Cohen's d_z = −2.33), RFS −6.1 (d_z = −1.88), RSS ‐12 − 33.9 (d_z = −1.30) and LPR ‐ HRQoL +20.0 (d_z = +2.17) (all p < 0.001). Thirty‐nine of 75 (52.0%) were responders. A twice‐daily PPI regimen was independently associated with response (adjusted odds ratio [ OR ] 4.96, 95% CI 1.41–17.43; p = 0.012) and higher baseline RSI with non‐response (adjusted OR 0.70 per point, 95% CI 0.56–0.87; p = 0.002).

Conclusions

Nebulised NAC with saline was associated with large improvements across symptom, laryngoscopic and quality‐of‐life domains in adults with LPS persisting despite PPI therapy and was well tolerated. As the study was uncontrolled and the saline vehicle may itself relieve symptoms, efficacy requires confirmation in a randomised trial against nebulised saline.

Schlagwörter

Stichwörter der Autor:innen

N‐acetylcysteinelaryngopharyngeal refluxlaryngopharyngeal symptomsnebulisers and vaporizerspersistent throat symptomsreflux symptom indextreatment outcome

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
  • Convergence Medical Institute, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.

ORCID-Profile: Sumin Yi, Han Wool John Sung, Bon Seok Koo, Jae Won Chang

Förderung

  • Chungnam National University

Zitieren

APA

Kim, S. H., Yi, S., Sung, H. W. J., Son, H. O., Koo, B. S., & Chang, J. W. (2026). Adjunctive Nebulised N‐Acetylcysteine for Laryngopharyngeal Symptoms Persisting Despite Proton‐Pump‐Inhibitor Therapy: A Prospective Single‐Arm Interventional Study. Clinical Otolaryngology. https://doi.org/10.1111/coa.70195

Vancouver

Kim SH, Yi S, Sung HWJ, Son HO, Koo BS, Chang JW. Adjunctive Nebulised N‐Acetylcysteine for Laryngopharyngeal Symptoms Persisting Despite Proton‐Pump‐Inhibitor Therapy: A Prospective Single‐Arm Interventional Study. Clinical Otolaryngology. 2026. doi:10.1111/coa.70195

BibTeX
@article{Kim2026,
  author = {Kim, Sang Heun and Yi, Sumin and Sung, Han Wool John and Son, Hyo One and Koo, Bon Seok and Chang, Jae Won},
  title = {Adjunctive Nebulised N‐Acetylcysteine for Laryngopharyngeal Symptoms Persisting Despite Proton‐Pump‐Inhibitor Therapy: A Prospective Single‐Arm Interventional Study},
  journal = {Clinical Otolaryngology},
  year = {2026},
  doi = {10.1111/coa.70195}
}
Kostenlos starten →